Beam Therapeutics Inc at Stifel Tailoring Genes: Genetic Medicines Day (Virtual) Transcript
Great. Good morning, everyone, continuing our session on our inaugural virtual genetic medicines' day.
My name is Dae Gon Ha, one of the biotech analysts at Stifel. Joining me for the next half-hour is Beam Therapeutics. And we've got John Evans, CEO of Beam Therapeutics joining us. So John, thank you very much.
Great to be here. Thank you.
Questions & Answers
So quick housekeeping. If you, in the audience, have any questions you'd like me to direct to John, please e-mail me at [email protected] or you can just use the chat function (technical difficulty) questions. So John, I knew this happens all the time and I hate to do this, but if you wouldn't mind providing us with an overview of the catalysts and milestones as well as your programs that we should keep an eye out for.
Absolutely.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
